The U.S. Food and Drug Administration has given St. Louis-based Mobius Therapeutics LLC the go-ahead to start production of a drug for use in eye surgery.
Mobius plans to have other St. Louis-area companies make and distribute the new drug, called Mitosol, which is FDA-approved for use in surgeries to treat glaucoma. Glaucoma is one of the leading causes of blindness in the United States.
